Johnson MD - Search Results

1

High-efficiency genotype analysis from formalin-fixed, paraffin-embedded tumor tissues.

Sikora MJ, Thibert JN, Salter J, Dowsett M, Johnson MD, Rae JM. Sikora MJ, et al. Among authors: johnson md. Pharmacogenomics J. 2011 Oct;11(5):348-58. doi: 10.1038/tpj.2010.50. Epub 2010 Jun 15. Pharmacogenomics J. 2011. PMID: 20548328 Free PMC article.

2

The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance.

Sikora MJ, Cordero KE, Larios JM, Johnson MD, Lippman ME, Rae JM. Sikora MJ, et al. Among authors: johnson md. Breast Cancer Res Treat. 2009 May;115(2):289-96. doi: 10.1007/s10549-008-0080-8. Epub 2008 Jun 4. Breast Cancer Res Treat. 2009. PMID: 18521740 Free PMC article.

3

Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples.

Rae JM, Cordero KE, Scheys JO, Lippman ME, Flockhart DA, Johnson MD. Rae JM, et al. Among authors: johnson md. Pharmacogenetics. 2003 Aug;13(8):501-7. doi: 10.1097/00008571-200308000-00008. Pharmacogenetics. 2003. PMID: 12893988

4

Efavirenz directly modulates the oestrogen receptor and induces breast cancer cell growth.

Sikora MJ, Rae JM, Johnson MD, Desta Z. Sikora MJ, et al. Among authors: johnson md. HIV Med. 2010 Oct 1;11(9):603-7. doi: 10.1111/j.1468-1293.2010.00831.x. Epub 2010 Jun 28. HIV Med. 2010. PMID: 20408889 Free PMC article.

5

Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation.

Sikora MJ, Strumba V, Lippman ME, Johnson MD, Rae JM. Sikora MJ, et al. Among authors: johnson md. Breast Cancer Res Treat. 2012 Aug;134(3):1027-39. doi: 10.1007/s10549-012-2032-6. Epub 2012 Mar 29. Breast Cancer Res Treat. 2012. PMID: 22456984 Free PMC article.

6

The CYP17A1 inhibitor abiraterone exhibits estrogen receptor agonist activity in breast cancer.

Capper CP, Larios JM, Sikora MJ, Johnson MD, Rae JM. Capper CP, et al. Among authors: johnson md. Breast Cancer Res Treat. 2016 May;157(1):23-30. doi: 10.1007/s10549-016-3774-3. Epub 2016 Apr 15. Breast Cancer Res Treat. 2016. PMID: 27083183

7

What does an orphan G-protein-coupled receptor have to do with estrogen?

Rae JM, Johnson MD. Rae JM, et al. Among authors: johnson md. Breast Cancer Res. 2005;7(6):243-4. doi: 10.1186/bcr1330. Epub 2005 Sep 29. Breast Cancer Res. 2005. PMID: 16280047 Free PMC article.

8

MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research.

Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD. Rae JM, et al. Among authors: johnson md. Breast Cancer Res Treat. 2007 Jul;104(1):13-9. doi: 10.1007/s10549-006-9392-8. Epub 2006 Sep 27. Breast Cancer Res Treat. 2007. PMID: 17004106

9

Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties.

Rae JM, Ramus SJ, Waltham M, Armes JE, Campbell IG, Clarke R, Barndt RJ, Johnson MD, Thompson EW. Rae JM, et al. Among authors: johnson md. Clin Exp Metastasis. 2004;21(6):543-52. doi: 10.1007/s10585-004-3759-1. Clin Exp Metastasis. 2004. PMID: 15679052 Free article.

10

GREB 1 is a critical regulator of hormone dependent breast cancer growth.

Rae JM, Johnson MD, Scheys JO, Cordero KE, Larios JM, Lippman ME. Rae JM, et al. Among authors: johnson md. Breast Cancer Res Treat. 2005 Jul;92(2):141-9. doi: 10.1007/s10549-005-1483-4. Breast Cancer Res Treat. 2005. PMID: 15986123 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,240 results

Search Page

Filters